3549 results for «240»

Filter By

3549 results

Tailored transfemoral TAVI in complex anatomies - LIVE Case

11 Sep 2025 – From PCR Rio Valves 2025

Join this live educational session from Hospital Copa D'Or in Rio de Janeiro, Brazil, focusing on tailored transfemoral TAVI in patients with complex anatomies. Gain critical insights into pre-procedural planning, decision-making strategies for high-risk cases, and technical nuances that optimize procedural success, all demonstrated through expert...

Tailored transfemoral TAVI in complex anatomies - LIVE Case

All you need to know about transcatheter tricuspid therapies

11 Sep 2025 – From PCR Rio Valves 2025

Delve into the evolving field of transcatheter tricuspid therapies with this comprehensive session. Understand tricuspid valve anatomy and imaging modalities, discuss optimal timing for intervention in tricuspid regurgitation, and review current and emerging transcatheter treatment options. Case presentations illustrate practical applications and outcomes to support clinical...

All you need to know about transcatheter tricuspid therapies

Welcome to PCR Rio Valves 2025

11 Sep 2025 – From PCR Rio Valves 2025

Welcome to PCR Rio Valves 2025, the premier event dedicated to advancements in structural heart interventions. This session sets the stage for an engaging congress filled with cutting-edge research, expert discussions, and innovative valve therapies shaping the future of cardiology.

Welcome to PCR Rio Valves 2025

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Best of #AHA20 Interventional Trials

19 Nov 2020

Mirvat Al Asnag provides reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 virtual edition of the American Heart Association Congress.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Best of #AHA20 Interventional Trials
Didn’t find what you were looking for?